Form 4: InMed Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
Vivo Opportunity, LLC and 3 others reported changes in beneficial ownership of InMed Pharmaceuticals Inc. common stock on July 14, 2026.
Summary
- Open-market purchase: acquired 4,882 Common Shares at $1.55 ($7,567) on July 14, 2026; holds 729,277 after (Indirect).
- Open-market purchase: acquired 493 Common Shares at $1.55 ($764) on July 14, 2026; holds 73,628 after (Indirect).
- Open-market purchase: acquired 13,761 Common Shares at $1.55 ($21,330) on July 15, 2026; holds 743,038 after (Indirect).
- Open-market purchase: acquired 1,389 Common Shares at $1.55 ($2,153) on July 15, 2026; holds 75,017 after (Indirect).
- Open-market purchase: acquired 19 Common Shares at $1.55 ($29) on July 16, 2026; holds 743,057 after (Indirect).
- Open-market purchase: acquired 2 Common Shares at $1.55 ($3) on July 16, 2026; holds 75,019 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $31,846, committing personal capital to the stock.
Insider Transactions
Vivo Opportunity, LLC — 10% owner
Vivo Opportunity Fund Holdings, L.P. — 10% owner
Vivo Opportunity Cayman, LLC — 10% owner
Vivo Opportunity Cayman Fund, L.P. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Open-market purchase | Common Shares | 4,882 | $2 | $7.6K | 729,277 |
| 2026-07-14 | Open-market purchase | Common Shares | 493 | $2 | $764 | 73,628 |
| 2026-07-15 | Open-market purchase | Common Shares | 13,761 | $2 | $21.3K | 743,038 |
| 2026-07-15 | Open-market purchase | Common Shares | 1,389 | $2 | $2.2K | 75,017 |
| 2026-07-16 | Open-market purchase | Common Shares | 19 | $2 | $29 | 743,057 |
| 2026-07-16 | Open-market purchase | Common Shares | 2 | $2 | $3 | 75,019 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Open-market purchase (4,882 shares) |
| 2026-07-14 | Open-market purchase (493 shares) |
| 2026-07-15 | Open-market purchase (13,761 shares) |
| 2026-07-15 | Open-market purchase (1,389 shares) |
| 2026-07-16 | Open-market purchase (19 shares) |
| 2026-07-16 | Open-market purchase (2 shares) |
Keywords
insider transaction, Form 4, INM, InMed Pharmaceuticals Inc., bullish, Vivo Opportunity, LLC, Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.